| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |